Land: Armenië
Taal: Engels
Bron: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)
Famar Orleans
N02BE51
paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)
650mg+10mg+20mg
powder for oral solution with lemon flavour
(10) sachets 15g
OTC
Registered
2019-06-05
N O V A R T I S Global Drug Regulatory Affairs THERAFLU EXTRA LEMON Powder in Sachets Actives substances Paracetamol 650mg; Pheniramine maleate 20mg; Phenylephrine hydrochloride 10mg; SUMMARY OF PRODUCT CHARACTERISTICS Property of Novartis Consumer Health SA Confidential May not be used, divulged, published or otherwise disclosed without the consent of Novartis Consumer Health SA TABLE OF CONTENTS 1. NAME OF THE MEDICINAL PRODUCT ......................................................................... 3 2. QUALITATIVE AND QUANTITATIVE COMPOSITION .............................................. 3 3. PHARMACEUTICAL FORM .............................................................................................. 3 4. CLINICAL PARTICULARS ................................................................................................. 3 4.1 THERAPEUTIC INDICATIONS ................................................................................................ 3 4.2. POSOLOGY AND METHOD OF ADMINISTRATION ................................................................... 3 4.3. CONTRAINDICATIONS ....................................................................................................... 3 4.4. SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE .................................................... 4 4.5. INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION ......... 4 4.6. PREGNANCY AND LACTATION ............................................................................................. 5 4.7. EFFECTS ON ABILITY TO DRIVE AND USE MACHINES ............................................................ 5 4.8. UNDESIRABLE EFFECTS .......................................................................................................6 4.9. OVERDOSE ....................................................................................................................... 6 5. PHARMACOLOGICAL PROPERTIES .............................................................................. 7 5.1. PHARMACODYNA Lees het volledige document